For information, please contact Nicole Levesque (levesque@hsph.harvard.edu, 617-432-4902)
More information is available on the main Symposium Page.
May 13, 2024
(All times below are EDT)
Harvard T.H. Chan School of Public Health – Snyder Auditorium
Also available via Zoom
8:30 – 8:45 | Welcome & Introduction |
8:45 – 9:00 | Opening Remarks Andrea Baccarelli, Dean of the Faculty, Harvard T.H. Chan School of Public Health |
9:00 – 10:00 | Jun Yu, Li Ka Shing Institute of Health Sciences “<talk title tbd>” |
10:00 – 10:30 | Emily Vogtmann, National Cancer Institute “Current and future directions for the study of the human oral microbiome and cancer risk” |
10:30 – 10:45 | Short talk “talk title tbd” |
10:45 – 11:00 | Short talk “talk title tbd” |
11:00 – 11:30 | Break |
11:30 – 12:00 | Robert Holt, BC Research Cancer Institute “Can we vaccinate against the oncomicrobe Fusobacterium nucleatum?” |
12:00 – 12:30 | Francesco Asnicar, University of Trento “Human gut microbiome as a tool in oncology” |
12:30 – 1:30 | Lunch Break |
1:30 – 2:15 | Discussion panel: “Commercialization of Microbiome Science” Participants: Damian Cabral (Merck), Anik Debnath (Tenza), Phil Strandwitz (Holobiome), Sabrina Yang (Empress Therapeutics), Koji Yasuda (Fast Track Initiative), Jeremy Wilkinson (PacBio) |
2:15 – 2:30 | Short talk “talk title tbd” |
2:30 – 2:45 | Short talk, “talk title tbd” |
2:45 – 3:15 | Break |
3:15 – 3:45 | Florencia McAllister, MD Anderson Cancer Center “Gut-tumors microbial axis in pancreatic cancer and beyond” |
3:45 – 4:45 | Marcel van den Brink, City of Hope “talk title tbd” |
4:45 – 5:00 | Closing Remarks |
5:00 – 6:30 | Poster Reception (also available online all day) |